Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Privosegtor
Other

Privosegtor

Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 08, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Business
Oculis to Present at Goldman Sachs Conference
Oculis, a global biopharmaceutical company, announced its management's participation in a fireside chat at the 47th Annual Goldman Sachs Global Healthcare Conference on June 9, 2026, in Miami, FL. Dr. Riad Sherif, CEO of Oculis,…
Impact: Privosegtor is a novel neuroprotective candidate by Oculis that received Breakthrough Therapy and PRIME designations, with a potential market opportunity of over $7 billion in the U.S. alone.
Jun 08, 2026 · 6 articles
Key Actions (2)
70 United States — Food and Drug Administration granted designation PrivosegtorOculis to Present at...
70 European Union — European Medicines Agency granted designation PrivosegtorOculis to Present at...
NEWSDESK
Track Privosegtor live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.